Found: 287
Select item for more details and to access through your institution.
Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 8, p. 501, doi. 10.1002/acr2.11259
- By:
- Publication type:
- Article
Passing the torch: a faculty mentoring program at one school of nursing.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
PASSING THE TORCH: A Faculty Mentoring Program at One School of Nursing.
- Published in:
- Nursing Education Perspectives (National League for Nursing), 2008, v. 29, n. 1, p. 29
- By:
- Publication type:
- Article
A History of the Book in America, vol. 2: An Extensive Republic; Print, Culture, and Society in the New Nation, 1790–1840.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
The Religious History of American Women: Reimagining the Past.
- Published in:
- 2007
- By:
- Publication type:
- Book Review
Extending Maintenance Dosing Intervals for Guselkumab in the Treatment of Patients With Psoriasis.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 8, p. 856, doi. 10.1001/jamadermatol.2024.2131
- By:
- Publication type:
- Article
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The Best Psoriasis Medications Emerge.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 1, p. 99, doi. 10.1001/jamadermatol.2023.4445
- By:
- Publication type:
- Article
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 6, p. 596, doi. 10.1001/jamadermatol.2023.0627
- By:
- Publication type:
- Article
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 2, p. 182, doi. 10.1001/jamadermatol.2022.5534
- By:
- Publication type:
- Article
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2022, v. 158, n. 12, p. 1394, doi. 10.1001/jamadermatol.2022.3862
- By:
- Publication type:
- Article
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab.
- Published in:
- JAMA Dermatology, 2022, v. 158, n. 11, p. 1327, doi. 10.1001/jamadermatol.2022.3488
- By:
- Publication type:
- Article
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Predicting Clinical Responses to Ustekinumab: Progress Toward a Future of Personalized Medicine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Implications for Biologic Therapy: Staphylococcus aureus Decolonization of Individuals With a History of Recurrent Skin and Soft-Tissue Infections.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 8, p. 986, doi. 10.1001/jamadermatol.2013.4405
- By:
- Publication type:
- Article
Clustering of Neonatal Deaths in Bangladesh: Results From the Projahnmo Studies.
- Published in:
- Paediatric & Perinatal Epidemiology, 2013, v. 27, n. 2, p. 165, doi. 10.1111/ppe.12032
- By:
- Publication type:
- Article
WIDESPREAD PRIMARY CUTANEOUS INFECTION WITH <em> MYCOBACTERIUM FORTUITUM</em>.
- Published in:
- International Journal of Dermatology, 1993, v. 32, n. 7, p. 512, doi. 10.1111/j.1365-4362.1993.tb02836.x
- By:
- Publication type:
- Article
PORPHYRIA CUTANEA TARDA AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION.
- Published in:
- 1992
- By:
- Publication type:
- Report
CUTANEOUS CRYPTOCOCCOSIS MIMICKING KAPOSI'S SARCOMA AS THE INITIAL MANIFESTATION OF DISSEMINATED DISEASE.
- Published in:
- International Journal of Dermatology, 1992, v. 31, n. 4, p. 279, doi. 10.1111/j.1365-4362.1992.tb03572.x
- By:
- Publication type:
- Article
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 4, p. 669, doi. 10.1007/s40257-024-00855-2
- By:
- Publication type:
- Article
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 6, p. 939, doi. 10.1007/s40257-023-00806-3
- By:
- Publication type:
- Article
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 1, p. 139, doi. 10.1007/s40257-023-00817-0
- By:
- Publication type:
- Article
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 6, p. 913, doi. 10.1007/s40257-023-00809-0
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 3, p. 365, doi. 10.1007/s40257-022-00683-2
- By:
- Publication type:
- Article
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
- Published in:
- American Journal of Clinical Dermatology, 2021, v. 22, n. 1, p. 101, doi. 10.1007/s40257-020-00577-1
- By:
- Publication type:
- Article
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 4, p. 567, doi. 10.1007/s40257-020-00527-x
- By:
- Publication type:
- Article
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 1, p. 119, doi. 10.1007/s40257-019-00478-y
- By:
- Publication type:
- Article
Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 6, p. 863, doi. 10.1007/s40257-019-00466-2
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3).
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 457, doi. 10.1007/s40257-018-0353-x
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3).
- Published in:
- American Journal of Clinical Dermatology, 2017, v. 18, n. 2, p. 273, doi. 10.1007/s40257-016-0246-9
- By:
- Publication type:
- Article
A Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis.
- Published in:
- American Journal of Clinical Dermatology, 2016, v. 17, n. 4, p. 329, doi. 10.1007/s40257-016-0206-4
- By:
- Publication type:
- Article
Hippie Modernism: The Struggle for Utopia.
- Published in:
- Springerin, 2016, n. 3, p. 72
- By:
- Publication type:
- Article
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1882-2
- By:
- Publication type:
- Article
"RUSSIA PUTS COMPARATIVELY LITTLE EFFORT INTO USING SOFT POWER IN THE SOUTH CAUCASUS".
- Published in:
- 2010
- By:
- Publication type:
- Interview
Cestode infection in 2 dogs: cytologic findings in liver and a mesenteric lymph node.
- Published in:
- Veterinary Clinical Pathology, 2013, v. 42, n. 1, p. 103, doi. 10.1111/vcp.12016
- By:
- Publication type:
- Article
What is your diagnosis? Urine sediment from a southern California cat with weight loss.
- Published in:
- Veterinary Clinical Pathology, 2010, v. 39, n. 4, p. 517, doi. 10.1111/j.1939-165X.2010.00272.x
- By:
- Publication type:
- Article
Human skin Langerhans cells are targets of dengue virus infection.
- Published in:
- Nature Medicine, 2000, v. 6, n. 7, p. 816, doi. 10.1038/77553
- By:
- Publication type:
- Article
Correction to: From idea to systems solution: enhancing access to primary care in Malawi.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Gilbert Tennent, Son of Thunder: A Case Study of Continental Pietism's Impact on tbe First Great Awakening in the Middle Colonies.
- Published in:
- 1987
- By:
- Publication type:
- Book Review
Get Rid of the Gray: Make Accessibility More Black and White!
- Published in:
- Internet Learning Journal, 2014, v. 3, n. 1, p. 17
- By:
- Publication type:
- Article
Stakeholder perspectives on European priorities for comprehensive liver cancer control: a conjoint analysis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article